HK1041922A1 - An assay to detect a binding partner - Google Patents

An assay to detect a binding partner

Info

Publication number
HK1041922A1
HK1041922A1 HK02103468.5A HK02103468A HK1041922A1 HK 1041922 A1 HK1041922 A1 HK 1041922A1 HK 02103468 A HK02103468 A HK 02103468A HK 1041922 A1 HK1041922 A1 HK 1041922A1
Authority
HK
Hong Kong
Prior art keywords
assay
detect
binding partner
leukemia
sample
Prior art date
Application number
HK02103468.5A
Other languages
English (en)
Inventor
Richard Ian Christopherson
Remedios Cristobal Guillermo Dos
Original Assignee
Medsaic Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPP7916A external-priority patent/AUPP791698A0/en
Priority claimed from AUPQ0425A external-priority patent/AUPQ042599A0/en
Application filed by Medsaic Pty Ltd filed Critical Medsaic Pty Ltd
Publication of HK1041922A1 publication Critical patent/HK1041922A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Basic Packing Technique (AREA)
  • Motorcycle And Bicycle Frame (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK02103468.5A 1998-12-23 2002-05-07 An assay to detect a binding partner HK1041922A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP7916A AUPP791698A0 (en) 1998-12-23 1998-12-23 An assay
AUPQ0425A AUPQ042599A0 (en) 1999-05-18 1999-05-18 An assay-ii
PCT/AU1999/001156 WO2000039580A1 (en) 1998-12-23 1999-12-23 An assay to detect a binding partner

Publications (1)

Publication Number Publication Date
HK1041922A1 true HK1041922A1 (en) 2002-07-26

Family

ID=25645962

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02103468.5A HK1041922A1 (en) 1998-12-23 2002-05-07 An assay to detect a binding partner

Country Status (15)

Country Link
US (1) US7560226B2 (de)
EP (1) EP1151300B1 (de)
JP (1) JP4763135B2 (de)
KR (1) KR100795757B1 (de)
CN (1) CN1231761C (de)
AT (1) ATE466280T1 (de)
BR (1) BR9916449A (de)
CA (1) CA2356286C (de)
DE (1) DE69942314D1 (de)
DK (1) DK1151300T3 (de)
ES (1) ES2344180T3 (de)
HK (1) HK1041922A1 (de)
NZ (1) NZ525421A (de)
PT (1) PT1151300E (de)
WO (1) WO2000039580A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002502038A (ja) * 1998-01-29 2002-01-22 ミラー，サミュエル プロテオーム分析のための高密度アレイ及びその方法及び組成物
AUPR005600A0 (en) * 2000-09-12 2000-10-05 University Of Sydney, The Diagnostic assay
EP1344065A2 (de) 2000-12-14 2003-09-17 Paul Stroobant Proteomische bestimmung durch phagensonden
EP1248108B1 (de) * 2001-03-29 2011-08-31 Canon Kabushiki Kaisha Verfahren zum Zellscreening und dafür geeignete Substrata
JP4594588B2 (ja) * 2001-04-10 2010-12-08 ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニヴァーシティ 抗体特異的プロファイルの治療的および診断的使用方法
EP1412535A4 (de) * 2001-07-02 2007-08-22 Univ Leland Stanford Junior Mikroarrays zur phänotypisierung und manipulation von zellen
US7718387B2 (en) 2001-09-20 2010-05-18 Board Of Regents, The University Of Texas System Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
EP2299274A1 (de) 2002-03-07 2011-03-23 Medical Research Council SCD Fingerabdrücke
AU2003278168A1 (en) * 2002-06-20 2004-01-06 Paul Stroobant Improved methods for performing differential capture proteomics
DE10236101A1 (de) * 2002-08-05 2004-02-26 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Verfahren und Kit zur Durchführung funktioneller Tests an biologischen Zellen
WO2004106925A2 (en) * 2003-03-03 2004-12-09 Nagaoka & Co.Ltd. Methods and apparatus for use in detection and quantitation of various cell types and use of optical bio-disc for performing same
US20040235027A1 (en) * 2003-03-31 2004-11-25 Regent Of The University Of California Preparation and application of ligand-biopolymer conjugates
WO2004088318A1 (en) * 2003-04-04 2004-10-14 Biacore Ab Method and kit for cell analyte assay
SE0301058D0 (sv) 2003-04-10 2003-04-10 Biacore Ab Method and kit for cell analyte assay
US8546082B2 (en) * 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US20080138808A1 (en) * 2003-09-11 2008-06-12 Hall Thomas A Methods for identification of sepsis-causing bacteria
US20120122101A1 (en) 2003-09-11 2012-05-17 Rangarajan Sampath Compositions for use in identification of bacteria
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US20050069958A1 (en) * 2003-09-26 2005-03-31 Mills Rhonda A. Method for simultaneous evaluation of a sample containing a cellular target and a soluble analyte
DE102004039628A1 (de) * 2004-08-10 2006-02-23 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Trägerplatte zur Durchführung funktioneller Tests an biologischen Zellen sowie Verfahren zur Beschichtung der Trägerplatte
AU2006247027A1 (en) * 2005-05-18 2006-11-23 Wyeth Leukemia disease genes and uses thereof
WO2006132666A1 (en) * 2005-06-06 2006-12-14 Decision Biomarkers, Inc. Assays based on liquid flow over arrays
US20070042443A1 (en) 2005-08-17 2007-02-22 Quest Diagnostics Investments Incorporated Hematopoietic cell phenotyping using free circulating cellular markers
CN101346626A (zh) * 2005-10-29 2009-01-14 拜尔技术服务有限责任公司 用于测定具有生物来源和复杂组成的样品中一种或多种分析物的方法及其用途
US20070105165A1 (en) * 2005-11-04 2007-05-10 Charles Goolsby Composite profiles of cell antigens and target signal transduction proteins for analysis and clinical management of hematologic cancers
WO2007062466A1 (en) 2005-11-29 2007-06-07 The University Of Sydney Demibodies: dimerisation-activated therapeutic agents
WO2007087370A2 (en) * 2006-01-25 2007-08-02 Caprion Pharmaceuticals, Inc. Tat-038 and methods of assessing and treating cancer
US8768629B2 (en) * 2009-02-11 2014-07-01 Caris Mpi, Inc. Molecular profiling of tumors
CN101449162B (zh) 2006-05-18 2013-07-31 分子压型学会股份有限公司 确定针对病状的个性化医疗介入的系统和方法
WO2009108932A2 (en) * 2008-02-28 2009-09-03 The Johns Hopkins University Selectin ligands useful in the diagnosis and treatment of cancer
GB0818614D0 (en) * 2008-10-10 2008-11-19 Univ Dublin City Platelet Analysis
CA2739675C (en) * 2008-10-14 2020-12-01 Caris Mpi, Inc. Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type
EP2350320A4 (de) 2008-11-12 2012-11-14 Caris Life Sciences Luxembourg Holdings Verfahren und systeme zur verwendung von exosomen zur bestimmung von phänotypen
CA2791905A1 (en) 2010-03-01 2011-09-09 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Biomarkers for theranostics
KR20130043104A (ko) 2010-04-06 2013-04-29 카리스 라이프 사이언스 룩셈부르크 홀딩스 질병용 순환 생물학적 지표들
WO2012048372A1 (en) * 2010-10-11 2012-04-19 Medsaic Pty Ltd Assay for disease detection
US9506923B2 (en) 2011-08-12 2016-11-29 Lsi Medience Corporation Method of diagnosing surgical site infections
CN103235124A (zh) * 2013-04-22 2013-08-07 复旦大学 一种基于硝酸纤维素膜的便捷癌细胞捕获芯片
US10208290B2 (en) * 2013-06-21 2019-02-19 The Johns Hopkins University Virion display array for profiling functions and interactions of human membrane proteins
US20180031575A1 (en) * 2014-11-20 2018-02-01 Ge Healthcare Uk Limited Detecting Dementia and Alzheimer's Disease Associated Biomarkers Stabilized on Solid Support Materials
CN105005484B (zh) * 2015-08-12 2021-04-20 厦门雅基软件有限公司 一种跨平台游戏开发工具的事件分发方法
JP2020526201A (ja) * 2017-07-08 2020-08-31 ザ ジェネラル ホスピタル コーポレイション アルツハイマー病の治療のための治療薬または治療剤を同定するためのスクリーニング用プラットフォーム

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA822896B (en) * 1981-04-29 1982-12-29 Ciba Geigy New devices and kits for immunological analysis
US4591570A (en) * 1983-02-02 1986-05-27 Centocor, Inc. Matrix of antibody-coated spots for determination of antigens
US4797356A (en) 1985-12-02 1989-01-10 Konishiroku Photo Industries, Co., Ltd Monoclonal antibodies specific to glactosyltransferase isoenzyme II and their use in cancer immunoassays
US5426029A (en) * 1986-03-31 1995-06-20 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using leukocyte surface antigens
US5217869A (en) 1987-10-13 1993-06-08 Terrapin Technologies, Inc. Method to produce immunodiagnostic reagents
GB8810400D0 (en) * 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US5059522A (en) * 1988-08-18 1991-10-22 Wayne Lawrence G Intrinsic enzyme dot blot immunoassay or indentification of microorganisms
US6040138A (en) * 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5532135A (en) 1990-02-02 1996-07-02 Cancer Research Fund Of Contra Costa Solid-phase competitive assay utilizing a fusion protein
US5726064A (en) * 1990-11-22 1998-03-10 Applied Research Systems Ars Holding Nv Method of assay having calibration within the assay
US5234816A (en) * 1991-07-12 1993-08-10 Becton, Dickinson And Company Method for the classification and monitoring of leukemias
US5597735A (en) * 1992-05-11 1997-01-28 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Health And Welfare Glycolipids for serodiagnosis of tuberculosis and leprosy
JPH07508179A (ja) * 1992-08-21 1995-09-14 シェリング・コーポレーション ヒトインターロイキン−１３
ES2051651B1 (es) * 1992-12-10 1995-01-01 Univ Salamanca Procedimiento para la cuantificacion simultanea, en una sola medicion, de los principales tipos de linfocitos humanos y sus subpoblaciones.
ES2157227T3 (es) * 1993-02-09 2001-08-16 Becton Dickinson Co Asignacion automatica del linaje de leucemias agudas mediante citometria de flujo.
AU7556994A (en) * 1993-08-13 1995-03-14 Molecular Geriatrics Corporation Methods for the diagnosis of alzheimer's disease
US5692220A (en) * 1993-09-02 1997-11-25 Coulter Corporation Decision support system and method for diagnosis consultation in laboratory hematopathology
AU691529B2 (en) * 1993-10-06 1998-05-21 University Of Florida Research Foundation, Inc. Stem cell proliferation factor
US5861158A (en) * 1993-11-17 1999-01-19 The United States Of America As Represented By The Deptartment Of Health And Human Services Method and composition for transfer of active tumor-specific immunization from an immunized allogeneic bone marrow donor
JP3533541B2 (ja) * 1995-01-25 2004-05-31 旭メディカル株式会社 細胞選択フィルター
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
US6265150B1 (en) * 1995-06-07 2001-07-24 Becton Dickinson & Company Phage antibodies
US5968513A (en) 1996-06-24 1999-10-19 University Of Maryland Biotechnology Institute Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin
WO1998008083A1 (en) * 1996-08-20 1998-02-26 Motorola Inc. Method and apparatus for detecting predetermined molecular structures in a sample
US6087102A (en) 1998-01-07 2000-07-11 Clontech Laboratories, Inc. Polymeric arrays and methods for their use in binding assays
EP2189791A3 (de) 1998-02-04 2011-03-09 Life Technologies Corporation Mikroarrays und Verwendungen dafür

Also Published As

Publication number Publication date
ES2344180T3 (es) 2010-08-19
NZ525421A (en) 2004-10-29
CN1334922A (zh) 2002-02-06
JP4763135B2 (ja) 2011-08-31
DE69942314D1 (de) 2010-06-10
KR20010093221A (ko) 2001-10-27
ATE466280T1 (de) 2010-05-15
DK1151300T3 (da) 2010-07-12
JP2002533723A (ja) 2002-10-08
US20020019018A1 (en) 2002-02-14
KR100795757B1 (ko) 2008-01-21
EP1151300B1 (de) 2010-04-28
EP1151300A1 (de) 2001-11-07
EP1151300A4 (de) 2002-07-31
PT1151300E (pt) 2010-06-21
US7560226B2 (en) 2009-07-14
CN1231761C (zh) 2005-12-14
WO2000039580A1 (en) 2000-07-06
CA2356286A1 (en) 2000-07-06
CA2356286C (en) 2010-12-21
BR9916449A (pt) 2002-01-22

Similar Documents

Publication Publication Date Title
HK1041922A1 (en) An assay to detect a binding partner
TR200000565T2 (tr) Biyolojik örneklerdeki analiz bileşenlerinin hızlı analizi için yöntem
EP0797777A4 (de) Vorrichtung zur durchführung eines oder mehrerer kompetitiver ummunoassays
ES2187622T3 (es) Reactivos y dispositivos de ensayo.
DE69521104D1 (de) Spezifische Bindungstests und Reagenzien dafür
NZ306051A (en) Testing using electrochemiluminescence
TR199902473T2 (xx) Gen s�ralay�c� ve y�ntemler.
ES2001811A6 (es) Un nuevo material y un nuevo dispositivo utiles en ensayos de fijacionen fase solida para determinar la presencia o la cantidad de un analito en una muestra de ensayo
AU9066998A (en) Use of check surfaces for identifying disturbing samples in a detection procedure
AU3059499A (en) Solid-phase method for antigen and antibody determinations in bloodgroup serology, and test kit
NO20083610L (no) Cobalamin-maling
WO1997036994A8 (en) Sensor and modified membrane for the sensor
EP0829723A3 (de) Homogene Nachweisverfahren zur Bestimmung von Subpopulationen eines Analyten
DE69732034D1 (de) Assay-verfahren
IT1212845B (it) Saggio immunologico utilizzante un supporto cromogeno.
MY106963A (en) Agglutination assay.
ATE215095T1 (de) Immunologisches testverfahren zur quantifizierung von peg-modifiziertem humanem granulozyten- kolonie-stimulierender-faktor
ATE312203T1 (de) Dynamische bestimmung von analyten durch arrays auf inneren oberflächen
ES2107828T3 (es) Inmunoensayo.
ES2004066A6 (es) Metodo para analisis cualitativo y-o cuantitativo de antigenos,anticuerpos yno microorganismos u otras celulas y su correspondiente equipo
Hercher et al. Rapid identification of micro-organisms

Legal Events

Date Code Title Description
AS Change of ownership

Owner name: MEDSAIC PTY LIMITED

Free format text: FORMER OWNER(S): UNIVERSITY OF SYDNEY

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20131223